Regulation of multidrug resistance protein 1 by tumor necrosis factor α in cultured glial cells: Involvement of nuclear factor-κB and c-Jun N-terminal kinase signaling pathways

Molecular Pharmacology

Volumn 77, Issue 4, 2010, Pages 644-659

  Ronaldson, Patrick T ^a,b   Ashraf, Tamima ^a   Bendayan, Reina ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',7' BIS (2 CARBOXYETHYL) 5; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CARBOXYFLUORESCEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN P; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC TRANSCRIPTION; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT;

ANIMALS; ASTROCYTES; CELLS, CULTURED; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NF-KAPPA B; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950232828     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.059410     Document Type: Article

References (50)

1. Bachmeier CJ, Trickler WJ, and Miller DW (2004) Drug efflux transport properties of 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECFAM) and its fluorescent free acid, BCECF. J Pharm Sci 93:932-942.
2. Barbin G, Roisin MP, and Zalc B (2001) Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons. Neurochem Res 26:107-112.
3. Bauer B, Hartz AM, and Miller DS (2007) Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the bloodbrain barrier. Mol Pharmacol 71:667-675.
4. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98:13681-13686.
5. Bodner A, Toth PT, and Miller RJ (2004) Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity. Exp Neurol 188:246-253.
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Caccamo D, Campisi A, Currò M, Bramanti V, Tringali M, Li Volti G, Vanella A, and Ientile R (2005) Antioxidant treatment inhibited glutamate-evoked NF-kappaB activation in primary astroglial cell cultures. Neurotoxicology 26:915-921.
8. Chen RE and Thorner J (2007) Function and regulation in MAPK signaling pathways: lessons learned from the yeast Saccharomyces cerevisiae. Biochim Biophys Acta 1773:1311-1340.
9. Chen SH, Lin JK, Liu SH, Liang YC, and Lin-Shiau SY (2008) Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation. Toxicol Sci 102:138-149.
10. Cherrington NJ, Slitt AL, Li N, and Klaassen CD (2004) Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32:734-741.
11. Dallas S, Ronaldson PT, Bendayan M, and Bendayan R (2004) Multidrug resistance protein 1-mediated transport of saquinavir by microglia. Neuroreport 15:1183-1186.
12. Dallas S, Zhu X, Baruchel S, Schlichter L, and Bendayan R (2003) Functional expression of the multidrug resistance protein 1 in microglia. J Pharmacol Exp Ther 307:282-290.
13. Filipov NM, Seegal RF, and Lawrence DA (2005) Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol Sci 84:139-148.
14. Gabuzda D and Wang J (2000) Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neurovirol 6 (Suppl 1):S24-S32.
15. Ghorpade A, Holter S, Borgmann K, Persidsky R, and Wu L (2003) HIV-1 and IL-1 beta regulate Fas ligand expression in human astrocytes through the NF-kappa B pathway. J Neuroimmunol 141:141-149.
16. Hartz AM, Bauer B, Block ML, Hong JS, and Miller DS (2008) Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. FASEB J 22:2723-2733.
17. Hayashi A, Suzuki H, Itoh K, Yamamoto M, and Sugiyama Y (2003) Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem Biophys Res Commun 310:824-829.
18. Hayashi K, Pu H, Andras IE, Eum SY, Yamauchi A, Hennig B, and Toborek M (2006) HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier. J Cereb Blood Flow Metab 26:1052-1065.
19. Hayashi K, Pu H, Tian J, Andras IE, Lee YW, Hennig B, and Toborek M (2005) HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells. J Neurochem 93:1231-1241.
20. Hipfner DR, Mao Q, Qiu W, Leslie EM, Gao M, Deeley RG, and Cole SP (1999) Monoclonal antibodies that inhibit the transport function of the 190-kDa multidrug resistance protein, MRP. Localization of their epitopes to the nucleotide-binding domains of the protein. J Biol Chem 274:15420-15426.
21. Jorajuria S, Dereuddre-Bosquet N, Naissant-Storck K, Dormont D, and Clayette P (2004) Differential expression levels of MRP1, MRP4, and MRP5 in response to human immunodeficiency virus infection in human macrophages. Antimicrob Agents Chemother 48:1889-1891.
22. Kaul M, Zheng J, Okamoto S, Gendelman HE, and Lipton SA (2005) HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 12 (Suppl 1):878-892.
23. Kim JM, Oh YK, Lee JH, Im DY, Kim YJ, Youn J, Lee CH, Son H, Lee YS, Park JY, et al. (2005) Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK and NF-kappaB signal transduction pathway in astrocytes infected with Escherichia coli. Clin Exp Immunol 140:450-460.
24. Kolenko V, Bloom T, Rayman P, Bukowski R, Hsi E, and Finke J (1999) Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J Immunol 163:590-598.
25. Lee G, Babakhanian K, Ramaswamy M, Prat A, Wosik K, and Bendayan R (2007) Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rat brain microvessel endothelial and glial cell culture systems. Pharm Res 24:1262-1274.
26. Lee G and Piquette-MillerM(2003) Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays. J Pharm Sci 92:2152-2163.
27. Lickteig AJ, Slitt AL, Arkan MC, Karin M, and Cherrington NJ (2007) Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos 35:402-409.
28. Lin YZ, Yao SY, Veach RA, Torgerson TR, and Hawiger J (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270:14255-14258.
29. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, and Sacktor N (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9:205-221.
30. Meaden ER, Hoggard PG, Maher B, Khoo SH, and Back DJ (2001) Expression of P-glycoprotein and multidrug resistance-associated protein in healthy volunteers and HIV-infected patients. AIDS Res Hum Retroviruses 17:1329-1332.
31. Miller DS, Nobmann SN, Gutmann H, Toeroek M, Drewe J, and Fricker G (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol 58:1357-1367.
32. Muredda M, Nunoya K, Burtch-Wright RA, Kurz EU, Cole SP, and Deeley RG (2003) Cloning and characterization of the murine and rat mrp1 promoter regions. Mol Pharmacol 64:1259-1269.
33. Nair S, Hebbar V, Shen G, Gopalakrishnan A, Khor TO, Yu S, Xu C, and Kong AN (2008) Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. Pharm Res 25:387-399.
34. Oh SK, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J, and Kornfeld H (1992) Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr 5:251-256.
35. Ronaldson PT, Bendayan M, Gingras D, Piquette-Miller M, and Bendayan R (2004) Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures. J Neurochem 89:788-800.
36. Ronaldson PT and Bendayan R (2006) HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein. Mol Pharmacol 70:1087-1098.
37. Ronaldson PT and Bendayan R (2008) HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells. J Neurochem 106:1298-1313.
38. Ronaldson PT, Persidsky Y, and Bendayan R (2008) Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection. Glia 56:1711-1735.
39. Saha RN and Pahan K (2007) Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: Implications for HIV-associated dementia. Free Radic Biol Med 42:1866-1878.
40. Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds J, van Helvoort A, de Jong MC, Hooijberg JH, Mol CA, et al. (2000) Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res 60:5269-5277.
41. Shinoda C, Maruyama M, Fujishita T, Dohkan J, Oda H, Shinoda K, Yamada T, Miyabayashi K, Hayashi R, Kawagishi Y, et al. (2005) Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. Int J Cancer 117:21-31.
42. Song NY, Kim DH, Kim EH, Na HK, and Surh YJ (2009) 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. Ann N Y Acad Sci 1171:210-216.
43. Speth C, Dierich MP, and Sopper S (2005) HIV-infection of the central nervous system: the tightrope walk of innate immunity. Mol Immunol 42:213-228.
44. Torgerson TR, Colosia AD, Donahue JP, Lin YZ, and Hawiger J (1998) Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by non-invasive delivery of peptide carrying the nuclear localization sequence of NFkappa B p50. J Immunol 161:6084-6092.
45. Turriziani O, Gianotti N, Falasca F, Boni A, Vestri AR, Zoccoli A, Lazzarin A, and Antonelli G (2008) Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy. J Med Virol 80:766-771.
46. Wijnholds J, deLange EC, Scheffer GL, van den Berg DJ, Mol CA, van der Valk M, Schinkel AH, Scheper RJ, Breimer DD, and Borst P (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 105:279-285.
47. Williams GC, Liu A, Knipp G, and Sinko PJ (2002) Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). Antimicrob Agents Chemother 46:3456-3462.
48. Yi Y, Lee C, Liu QH, Freedman BD, and Collman RG (2004) Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis. J Neurovirol 10 (Suppl 1):91-96.
49. Zastre JA, Chan GN, Ronaldson PT, Ramaswamy M, Couraud PO, Romero IA, Weksler B, Bendayan M, and Bendayan R (2009) Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. J Neurosci Res 87:1023-1036.
50. Zhou J, Liu M, Aneja R, Chandra R, Lage H, and Joshi HC (2006) Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Res 66:445-452.